Muñoz-Fontela César, Mandinova Anna, Aaronson Stuart A, Lee Sam W
Heinrich Pette Institute, Leibniz Institute for Experimental Virology, Martinistrasse 52, 20251 Hamburg, Germany.
Cutaneous Biology Research Center, Massachusetts General Hospital and Harvard Medical School, Building 149 13th Street, Charlestown, Massachusetts 02129, USA.
Nat Rev Immunol. 2016 Dec;16(12):741-750. doi: 10.1038/nri.2016.99. Epub 2016 Sep 26.
Tumour-suppressor genes are indispensable for the maintenance of genomic integrity. Recently, several of these genes, including those encoding p53, PTEN, RB1 and ARF, have been implicated in immune responses and inflammatory diseases. In particular, the p53 tumour- suppressor pathway is involved in crucial aspects of tumour immunology and in homeostatic regulation of immune responses. Other studies have identified roles for p53 in various cellular processes, including metabolism and stem cell maintenance. Here, we discuss the emerging roles of p53 and other tumour-suppressor genes in tumour immunology, as well as in additional immunological settings, such as virus infection. This relatively unexplored area could yield important insights into the homeostatic control of immune cells in health and disease and facilitate the development of more effective immunotherapies. Consequently, tumour-suppressor genes are emerging as potential guardians of immune integrity.
肿瘤抑制基因对于维持基因组完整性不可或缺。最近,其中一些基因,包括编码p53、PTEN、RB1和ARF的基因,已被证明与免疫反应和炎症性疾病有关。特别是,p53肿瘤抑制途径参与肿瘤免疫学的关键方面以及免疫反应的稳态调节。其他研究已经确定p53在各种细胞过程中的作用,包括代谢和干细胞维持。在这里,我们讨论p53和其他肿瘤抑制基因在肿瘤免疫学以及其他免疫环境(如病毒感染)中的新作用。这个相对未被探索的领域可能会为健康和疾病中免疫细胞的稳态控制带来重要见解,并促进更有效的免疫疗法的发展。因此,肿瘤抑制基因正成为免疫完整性的潜在守护者。